Molecular Medicine Reports Molecular Medicine Reports 1791-2997 1791-3004 D.A. Spandidos 10.3892/mmr.2020.11215 MMR-22-02-1103 Review Primary open angle glaucoma genetics: The common variants and their clinical associations TrivliAlexandra 1 ZervouMaria I. 1 GoulielmosGeorge N. 1 SpandidosDemetrios A. 2 DetorakisEfstathios T. 3 Section of Molecular Pathology and Human Genetics, Department of Internal Medicine, School of Medicine, 71003 Heraklion, Greece Laboratory of Clinical Virology, Medical School, University of Crete, 71003 Heraklion, Greece Department of Ophthalmology, University Hospital of Heraklion, 71110 Heraklion, Greece Correspondence to: Dr Alexandra Trivli, Section of Molecular Pathology and Human Genetics, Department of Internal Medicine, School of Medicine, 71003 Heraklion, Greece, E-mail: alextrivli@yahoo.com 082020 09062020 22 2 1103 1110 25022020 03062020 Copyright: © Trivli et al. 2020 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Glaucoma is a group of progressive optic neuropathies that have in common characteristic optic nerve head changes, loss of retinal ganglion cells and visual field defects. Among the large family of glaucomas, primary open-angle glaucoma (POAG) is the most common type, a complex and heterogeneous disorder with environmental and genetic factors contributing to its pathogenesis. Approximately 5% of POAG is currently attributed to single-gene or Mendelian forms of glaucoma. Genetic linkage analysis and genome-wide association studies have identified various genomic loci, paving the path to understanding the pathogenesis of this enigmatic, blinding disease. In this review we summarize the most common variants reported thus far and their possible clinical correlations.

 glaucoma primary open-angle glaucoma genome-wide association studies endophenotype linkage genetics Introduction

Glaucoma represents a group of chronic and progressive optic neuropathies with distinctive pattern of progressive visual field loss and optic disc damage, and is the leading cause of irreversible blindness worldwide. This enigmatic and heterogeneous disease has affected 3.5% of the world's population with approximately 5.7 million people visually impaired and 3.1 million blind, and an estimate to affect 111.8 million people by 2040 (1). Primary open-angle glaucoma (POAG), the most common representative, is characterized by a normal, open anterior chamber angle and elevated intraocular pressure (IOP) or even normal IOP, named normal tension glaucoma (NTG). Two hallmark theories attempt to explain the pathway of the disease; the mechanical and vascular theory. Although both present postulated mechanisms of progressive retinal ganglion cell (RGC) damage and eventual optic neuropathy, the exact etiology still remains unknown (2). The well recognised risk factors for POAG include higher age, high IOP, decreased central corneal thickness (CCT), African descent, high myopia and a positive family history (3,4). Amongst them, high IOP remains the only modifiable risk factor for the development and prognostic factor for the progression of POAG (3).

POAG has long shown a strong genetic component with 60% of patients with a positive family history and family based studies identifying a 10-fold increased risk of POAG for first degree relatives (5). Heritability of POAG can be divided into two major categories: direct association (increased POAG risk) and indirect (increased risk for a component of the disease). The first one deals with several genes linked to POAG through family-based genetic linkage analysis, with major examples being myocilin (MYOC), optineurin (OPTN), WD repeat domain 36 (WDR36), cytochrome P450, family 1, subfamily B, polypeptide 1 (CYP1B1) and neurotrophin 4 (NTF4) (6–10). With heritability ranging from 0 (no genetic component) to 1 (phenotype determined by genes), these genes attribute to POAG heritability at ~0.81 (11). The second factor refers to the endophenotype traits related to POAG pathogenesis, highly heritable and polymorphic. Notable examples are IOP (0.55), vertical cup-to-disc ratio (VCDR=0.48–0.66), CCT (0.72), cup area (CA=0.75) and disc area (DA=0.72) (12,13).

Genome-wide association studies (GWAS) have been used in the past decade in an attempt to uncover genetic variants of complex diseases. For POAG, over 70 single-nucleotide polymorphisms (SNPs) have been identified and linked to POAG or its endophenotypes, changing our understanding of the molecular pathways of the disease (14). Identification of the genes associated with the disease may also provide useful information for both patients and their physicians, by enabling the design of genetic screening tests that may help physicians assess the risk of patients for disease as well as to differentiate between clinically similar disorders. Valuable research available has provided details for many SNPs related to POAG. In this review the authors summarize the most common variants, present their possible clinical correlations and highlight their interactions.

 Search strategy

A MEDLINE/PubMed search was performed for articles in English from January 2010 to January 2020. Keywords included glaucoma, primary open angle glaucoma, genetics, genetic association studies, GWAS and SNP. Further search was performed in the database upon relative findings in the articles.

 Genomic loci

Genetic linkage analysis was the first genetic decoding of glaucoma. Classically used for Mendelian traits or mutations in a single gene, this method reveals chromosomal regions associated with a specific phenotype. Followed by GWAS in various populations, a number of variants and interactions unfolded, thus forming the complicated image of POAG. These genomic loci are marked GLC1A through GLC1P and show high heterogeneity (14,15) (Table I).

 Common variants

Although a number of SNPs has been linked to POAG, those summarized in Table II, appear to be the most commonly studied in the literature.

MYOC/trabecular meshwork-induced glucocorticoid response protein (TIGR). Located on chromosome 1q24, MYOC encodes protein MYOC, which is believed to have a role in cytoskeletal function and represents the first gene to be associated with POAG (14). Mutations in MYOC (alternatively TIGR) are linked to the GLC1A locus (14,16). Over 100 POAG-associated mutations have been identified in the MYOC gene making it accountable for 3–5% of POAG cases (15). Primarily associated with juvenile-onset POAG, expresses an autosomal dominant and highly penetrant severe phenotype, with highly elevated IOP which often requires surgical management (10,17). A less severe form is observed in the adult onset form, the most prevalent one (10). Other associations include primary congenital glaucoma (18). The effect of MYOC mutations appears to be on the trabecular meshwork (TM) and aqueous humor outflow (19).

<sec> <title>CYP1B1

Located on chromosome 2p22.2, CYP1B1 belongs to the cytochrome P450 superfamily of enzymes. Mutations in CYP1B1, although classically linked to anterior segment dysgenesis and congenital glaucoma, may also contribute to the GLC1A phenotype through a digenic inheritance, acting as a modifier for MYOC (20).

 OPTN

Located on chromosome 10p13, OPTN encodes the coiled-coil containing protein OPTN that plays an important role in the maintenance of the Golgi complex, in membrane trafficking and exocytosis. Mutations in OPTN are linked to the GLC1E locus. Even though variable mutations have been recognised, E50K has been strongly linked to glaucoma (21). Primarily associated with NTG, it has also been reported in patients with amyotrophic lateral sclerosis (ALS) (22). A variety of interactions and cellular effects have been reported for OPTN, notably its role in autophagy and apoptosis (23,24). It has been reported that although MYOC overexpression has no effect on OPTN expression, OPTN overexpression upregulates endogenous MYOC in TM cells (25). Noteworthy, the most notable is the interaction of OPTN with TANK-binding kinase 1 (TBK1) as they may share a common pathway (23,26).

 TBK1

Located on chromosome 12q14, mutations in TBK1 are linked to the GLC1P locus (10). Responsible for approximately 1% of NTG through a copy number variant (CNV) consisting of duplications in the TBK1, mutations have also been reported in patients with ALS and other central nervous system disorders (22,27,28). TBK1 is a kinase that regulates the expression of genes in the NF-κB signaling pathway, playing an essential role in regulating inflammatory responses to foreign agents and is also implicated in autophagy (29).

 WDR36

Located on chromosome 5q22, WDR36 encodes a member of the WD repeat protein family that is involved in T-cell activation. Mutations in WDR36 are linked to the GLC1G locus (10). Linked to an increased risk for POAG, mutations in WDR36 were initially reported to be responsible for 1.6 to 17% of POAG (8,30,31). WDR36 appears to negatively affect TM cells via apoptotic cell death (32).

 NTF4

Located on chromosome 19q13.33, NTF4 encodes a neurotrophic factor that signals predominantly through the tyrosine kinase receptor B (TrkB) receptor tyrosine kinase. Mutations in NTF4 are linked to the GLC1O locus. Negatively affecting the activation of TrkB, NTF4 mutations have been found in 1.7% of POAG patients in a study of European patients (9).

 Ankyrin repeat and SOCS box containing 10 (ASB10)

Located on chromosome 7q36, ASB10 encodes a protein that is a member of the ASB family of proteins. Mutations in ASB10 are linked to the GLC1F locus (33). ASB10 transcription appears to reduce aqueous humor outflow facility (34).

 Atonal bHLH transcription factor 7 (ATOH7)

Located on chromosome 10q21, ATOH7 encodes a transcription factor that appears to play a role in the differentiation of the RGCs and determination of DA, possibly during embryogenesis. It is associated with DA, VCDR, CA and POAG risk (35,36).

 Caveolin1/caveolin2 (CAV1/CAV2)

Located on chromosome 7q31, CAVs are involved in a number of cellular processes such as transcellular transport, cell proliferation and signal transduction (37). CAV1 and CAV2 are found to be expressed in ciliary muscle, TM, Schlemm's canal and retinal cells, and variants in the CAV1/CAV2 region are associated with IOP changes, possibly through alterations of aqueous outflow resistance (37–39). A possible direct, cell type specific interaction of CAV1 with ATP-binding cassette, subfamily A, member 1 (ABCA1), also supports a possible role in POAG (40).

 Cyclin-dependent kinase inhibitor 2B antisense RNA 1 (CDKN2B-AS1)

Located on chromosome 9p21, in the CDKN2B-CDKN2A gene cluster, CDKN2B protein is expressed in the inner nuclear layers of the retina and the ganglion cell layer. CDKN2B-AS1 is detected in the retina, ciliary body and optic nerve and variants have been associated with VCDR changes and NTG especially in women, as well as various non-ocular disorders, namely myocardial infarction and intracranial aneurysms; an association of POAG risk and these conditions has not been made however (41–47).

 Six homeobox 6 (SIX6)

Located on chromosome 14q23, SIX6 gene encodes homeobox proteins, critical for ocular development. The protein encoded by this gene is a homeobox protein that is similar to the Drosophila ‘sine oculis’ gene product and is thought to be involved in eye development. Variants in this locus have been linked to POAG through VCDR, myopia and reduced retinal nerve fiber layer (RNFL) thickness. An interesting interaction of the POAG-risk His141 SIX6 variant with CDKN2B-AS1 has been proposed as the former has been shown to elevate expression of the latter. A possibly protective Asn141 SIX6 variant remains to be further observed (44,47,48–52).

 Transmembrane and coiled-coil domains protein 1 (TMCO1)

Located on chromosome 1q24.1, TMCO1 encodes a transmembrane protein playing a key role in calcium homeostasis. It is expressed, among other ocular tissues, in the TM and retina. Sequence variants have been associated with IOP and increased POAG risk to a degree of 1.7-fold per risk allele, making it a significant quantitative trait (46,50,53–55).

 ABCA1

Located on chromosome 9q31, ABCA1 encodes a protein complex associated with extracellular and intracellular membrane transport. Although the locus is mainly associated with familial high-density lipoprotein deficiency and Tangier's disease, ABCA1 is also expressed in numerous ocular tissues, namely TM, ciliary body and RGCs. Sequence variants have been linked to POAG and IOP, possibly through an inflammatory and neurodegenerative mechanism (56,57).

 Actin filament-associated protein 1 (AFAP1)

Located on chromosome 4p16.1, AFAP1 encodes an adaptor protein that modulates changes in actin filament integrity in response to cellular signals. It is expressed, among others, in the retina and TM cells. Sequence variants have been associated with POAG through a still unknown mechanism (41,57).

 RHO guanine nucleotide exchange factor 12 (ARHGEF12)

Located on chromosome 11q23.3, ARHGEF12 encodes a guanine nucleotide exchange factor (GEF) that may form a complex with G proteins and stimulate Rho-dependent signals. An intronic variant has been associated with POAG and IOP, possibly through activation of RhoA and subsequent ROCK activation, leading to decreased outflow and elevated IOP. An interesting interaction is that with ABCA1 protein, with ARHGEF12 preventing ABCA1 degradation (58–60).

 Thioredoxin reductase 2 (TXNRD2)

Located on chromosome 22q11, TXNRD2 gene encodes a mitochondrial protein important for scavenging reactive oxygen species in mitochondria. It belongs to the family of flavoenzymes that catalyze redox reactions, thus controlling the levels of reactive oxygen species. TXNRD2 is found, among others, in the retina and optic nerve and sequence variants have been associated with POAG, possibly through a protective effect of TXNRD2 against oxidative stress of the RGCs (41,61,62).

 Forkhead box C1 (FOXC1)

Located on chromosome 6p25.3, FOXC1 is found next to GDP-mannose 4,6-dehydratase (GMDS) gene. It encodes a protein that has been shown to play a role in the regulation of embryonic and ocular development. Although mainly linked to anterior segment dysgenesis and Axenfeld-Rieger syndrome, sequence variants within the GMDS gene as well as variants located upstream of FOXC1 have been associated with POAG (41,57).

 Ataxin 2 (ATXN2)

Located on chromosome 12q24.12, ATXN2 is involved in regulating mRNA translation through its interactions with the poly (A)-binding protein. It is also involved in the formation of stress granules and P-bodies, which also play roles in RNA regulation (63). ATXN2 is expressed, among others, in the ciliary body, retina, and optic nerve. Although mainly linked to spinocerebellar ataxia and ALS, variants in ATXN2 have been associated with POAG possibly through neurodegeneration (41,64).

 Growth arrest-specific 7 (GAS7)

Located on chromosome 17p13, GAS7 encodes a protein that plays a putative role in neuronal development as well as maturation and is primarily expressed in vivo, in terminally differentiated brain cells. GAS7 has been associated with increased cup volume and IOP (47,54,55,65).

 Galactosylceramidase (GALC)

Located on chromosome 14q31.3, GALC encodes a lysosomal enzyme called galactosylceramidase, which is mainly linked to Krabbe disease, a rare disorder of the myelin sheath with progressive optic neuropathy. GALC has been associated with a 5-fold increased risk of POAG when heterozygous for a CNV deletion (66,67).

 Additional genes associated with POAG

Single SNPs in the MYOC, COL8A2, COL1A1 and ZNF469 gene regions have shown marginal association with POAG in a study conducted in South Africa (68). Although the number of the subjects enrolled in the study was small, it was demonstrated that the main POAG-associated susceptibility alleles found in other populations, play a reduced role in populations of African ancestry. Moreover, a GWAS performed in India identified a novel candidate gene for POAG, called membrane palmitoylated protein 7 (MPP7), which is dysregulated under cyclic mechanical stress in the TM, thus causing dysfunction of cell to cell interaction (69), while another study in India led to an novel association of POAG with Opticin (OPTC) gene (70).

 Endophenotypes and clinical association

Endophenotypes are stable, heritable quantitative traits, disease independent, that are usually helpful in analysing heterogeneous or variably phenotypic diseases. For POAG, these traits include IOP, CCT, VCDR, DA and RNFL thickness and as mentioned, contribute separately in the heritability of the disease (14). Studying the Endophenotypes helped dissect the disease and focus on separate components that are linked to clinical practice; nonetheless the variety of POAG endophenotypes highlights the complexity of the disease (Fig. 1).

<sec> <title>IOP

Independent of the genetic component, IOP remains the only modifiable risk factor and IOP reduction the most commonly used treatment of POAG. Of the aforementioned genetic variants, TMCO1, CAV1/CAV2, ARHGEF12, ABCA1 and GAS7 have been linked to IOP through GWAS, among other susceptibility loci (43,54,55). Of great interest is that the combined heritability of these loci regarding IOP is less than 2%, meaning that the majority is still to be explained (55). This observation could mean that further investigating the IOP endophenotype could clarify its role in glaucoma both as a contributing factor and a therapeutic target.

 CCT

Well recognized as an independent risk factor for POAG, over 26 loci have been identified for CCT (3,71). With a highly heritable trait, CCT shows association with ethnicity, with lower values in populations of African descent (11,72). Of the many sequence variants identified for CCT, of interest is fibronectin type III domain-containing protein 3B (FNDC3B) which appears to be involved also in IOP changes (71).

 VCDR

Increased VCDR is one of the cardinal clinical signs of glaucomatous optic neuropathy. Of the above mentioned genetic variants, ATOH7, CDKN2B-AS1 and SIX6 have been linked to VCDR, among other susceptibility loci (73,74).

 DA and CA

For DA 14 loci have been identified, 5 of which are also associated with VCDR. Of these, perhaps the most interesting is ATOH7, associated with DA, CA and VCDR, that appears to affect the differentiation of the RGCs (35,73,74). Approximately 27 variants have been associated with CA, notably ATOH7, CDKN2B-AS1 and SIX6 which, as mentioned previously, have also been linked to VCDR (49,75).

 RNFL

Two susceptibility loci have been identified for RNFL thickness through linkage analysis. As previously discussed, a SIX6 coding variant is one of them (51,76).

 Conclusion

Since the turn of the century there has been an explosion of research using genetic and next generation, high-throughput DNA sequencing technologies and it is unquestionably expected that they will be extensively employed also for further investigation and diagnosis of glaucoma. We aimed to present the basic role of the most studied sequence variants regarding POAG and their complex interaction. Although many more have been identified and many remain to be further clarified, linkage analysis initially and, recently, GWAS, have opened the road to the admittedly enigmatic and heterogenic disease that is POAG. As regards the issue of genetic counselling, genetic testing for glaucoma may obviously be helpful in some specific situations, such as screening of family members with a known genetic mutation in autosomal dominant POAG of early onset, although at a population level this is not presently justified (77).

With various components and differential clinical expression, the identification of genetic factors either directly linked to the disease or endophenotype-related, brings us closer to understanding the molecular and cellular mechanisms and, eventually, to the development of efficient therapeutic approaches targeted at the root cause of the condition.

 Acknowledgements

Not applicable.

 Funding

No funding was received.

 Availability of data and materials

Not applicable.

 Authors' contributions

AT, ETD, GNG, DAS and MIZ conceived and designed the study. AT, GNG and ETD researched the literature, performed critical analysis and review of the literature and drafted the manuscript. DAS and MIZ critically revised the article for important intellectual content. All authors read and approved the final manuscript.

 Ethics approval and consent to participate

Not applicable

 Patient consent for publication

Not applicable.

 Competing interests

The authors declare that they have no competing interests. DAS is the Editor-in-Chief for the journal, but had no personal involvement in the reviewing process, or any influence in terms of adjudicating on the final decision, for this article.

 References ThamYCLiXWongTYQuigleyHAAungTChengCYGlobal prevalence of glaucoma and projections of glaucoma burden through 2040: A systematic review and meta-analysisOphthalmology12120812090201410.1016/j.ophtha.2014.05.01324974815 KwonYHFingertJHKuehnMHAlwardWLPrimary open-angle glaucomaN Engl J Med36011131124200910.1056/NEJMra080463019279343 GordonMOBeiserJABrandtJDHeuerDKHigginbothamEJJohnsonCAKeltnerJLMillerJPParrishRKIIWilsonMRThe Ocular Hypertension Treatment Study: Baseline factors that predict the onset of primary open-angle glaucomaArch Ophthalmol120714720, discussion 829–830200210.1001/archopht.120.6.71412049575 FanBJLeungYFWangNLamSCLiuYTamOSPangCPGenetic and environmental risk factors for primary open-angle glaucomaChin Med J (Engl)117706710200415161538 WolfsRCKlaverCCRamrattanRSvan DuijnCMHofmanAde JongPTGenetic risk of primary open-angle glaucoma. Population-based familial aggregation studyArch Ophthalmol11616401645199810.1001/archopht.116.12.16409869795 StoneEMFingertJHAlwardWLNguyenTDPolanskyJRSundenSLNishimuraDClarkAFNystuenANicholsBEIdentification of a gene that causes primary open angle glaucomaScience275668670199710.1126/science.275.5300.6689005853 RezaieTChildAHitchingsRBriceGMillerLCoca-PradosMHéonEKrupinTRitchRKreutzerDAdult-onset primary open-angle glaucoma caused by mutations in optineurinScience29510771079200210.1126/science.106690111834836 MonemiSSpaethGDaSilvaAPopinchalkSIlitchevELiebmannJRitchRHéonECrickRPChildAIdentification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1Hum Mol Genet14725733200510.1093/hmg/ddi06815677485 PasuttoFMatsumotoTMardinCYStichtHBrandstätterJHMichels-RautenstraussKWeisschuhNGramerERamdasWDvan KoolwijkLMHeterozygous NTF4 mutations impairing neurotrophin-4 signaling in patients with primary open-angle glaucomaAm J Hum Genet85447456200910.1016/j.ajhg.2009.08.01619765683 FingertJHPrimary open-angle glaucoma genesEye (Lond)25587595201110.1038/eye.2011.9721562585 CharlesworthJKramerPLDyerTDiegoVSamplesJRCraigJEMackeyDAHewittAWBlangeroJWirtzMKThe path to open-angle glaucoma gene discovery: Endophenotypic status of intraocular pressure, cup-to-disc ratio, and central corneal thicknessInvest Ophthalmol Vis Sci5135093514201010.1167/iovs.09-478620237253 KleinBEKleinRLeeKEHeritability of risk factors for primary open-angle glaucoma: The Beaver Dam Eye StudyInvest Ophthalmol Vis Sci455962200410.1167/iovs.03-051614691154 SanfilippoPGHewittAWHammondCJMackeyDAThe heritability of ocular traitsSurv Ophthalmol55561583201010.1016/j.survophthal.2010.07.00320851442 LiuYAllinghamRRMajor review: Molecular genetics of primary open-angle glaucomaExp Eye Res1606284201710.1016/j.exer.2017.05.00228499933 LiuYAllinghamRRMolecular genetics in glaucomaExp Eye Res93331339201110.1016/j.exer.2011.08.00721871452 SheffieldVCStoneEMAlwardWLDrackAVJohnsonATStrebLMNicholsBEGenetic linkage of familial open angle glaucoma to chromosome 1q21-q31Nat Genet44750199310.1038/ng0593-478513321 FingertJHHéonELiebmannJMYamamotoTCraigJERaitJKawaseKHohSTBuysYMDickinsonJAnalysis of myocilin mutations in 1703 glaucoma patients from five different populationsHum Mol Genet8899905199910.1093/hmg/8.5.89910196380 KaurKReddyABMukhopadhyayAMandalAKHasnainSERayKThomasRBalasubramanianDChakrabartiSMyocilin gene implicated in primary congenital glaucomaClin Genet67335340200510.1111/j.1399-0004.2005.00411.x15733270 DismukeWMChallaPNavarroIStamerWDLiuYHuman aqueous humor exosomesExp Eye Res1327377201510.1016/j.exer.2015.01.01925619138 KaurKMandalAKChakrabartiSPrimary congenital glaucoma and the involvement of CYP1B1Middle East Afr J Ophthalmol18716201110.4103/0974-9233.7587821572728 AungTRezaieTOkadaKViswanathanACChildAHBriceGBhattacharyaSSLehmannOJSarfaraziMHitchingsRAClinical features and course of patients with glaucoma with the E50K mutation in the optineurin geneInvest Ophthalmol Vis Sci4628162822200510.1167/iovs.04-113316043855 CirulliETLasseigneBNPetrovskiSSappPCDionPALeblondCSCouthouisJLuYFWangQKruegerBJFALS Sequencing ConsortiumExome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathwaysScience34714361441201510.1126/science.aaa365025700176 HeoJMOrdureauAPauloJARinehartJHarperJWThe PINK1-PARKIN mitochondrial ubiquitylation pathway drives a program of OPTN/NDP52 recruitment and TBK1 activation to promote mitophagyMol Cell60720201510.1016/j.molcel.2015.08.01626365381 SlowickaKVereeckeLvan LooGCellular functions of optineurin in health and diseaseTrends Immunol37621633201610.1016/j.it.2016.07.00227480243 ParkBCTibudanMSamaraweeraMShenXYueBYJTInteraction between two glaucoma genes, optineurin and myocilinGenes Cells12969979200710.1111/j.1365-2443.2007.01102.x17663725 MortonSHessonLPeggieMCohenPEnhanced binding of TBK1 by an optineurin mutant that causes a familial form of primary open angle glaucomaFEBS Lett5829971002200810.1016/j.febslet.2008.02.04718307994 LiuYGarrettMEYaspanBLBaileyJCLoomisSJBrilliantMBudenzDLChristenWGFingertJHGaasterlandDDNA copy number variants of known glaucoma genes in relation to primary open-angle glaucomaInvest Ophthalmol Vis Sci55825182582014b10.1167/iovs.14-15712 GijselinckIVan MosseveldeSvan der ZeeJSiebenAPhiltjensSHeemanBEngelborghsSVandenbulckeMDe BaetsGBäumerVBELNEU ConsortiumLoss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohortNeurology8521162125201510.1212/WNL.000000000000222026581300 MatsumotoGShimogoriTHattoriNNukinaNTBK1 controls autophagosomal engulfment of polyubiquitinated mitochondria through p62/SQSTM1 phosphorylationHum Mol Genet2444294442201510.1093/hmg/ddv17925972374 JanssenSFGorgelsTGRamdasWDKlaverCCvan DuijnCMJansoniusNMBergenAAThe vast complexity of primary open angle glaucoma: Disease genes, risks, molecular mechanisms and pathobiologyProg Retin Eye Res373167201310.1016/j.preteyeres.2013.09.00124055863 KramerPLSamplesJRMonemiSSykesRSarfaraziMWirtzMKThe role of the WDR36 gene on chromosome 5q22.1 in a large family with primary open-angle glaucoma mapped to this regionArch Ophthalmol12413281331200610.1001/archopht.124.9.132816966629 GallenbergerMMeinelDMKroeberMWegnerMMilkereitPBöslMRTammERLack of WDR36 leads to preimplantation embryonic lethality in mice and delays the formation of small subunit ribosomal RNA in human cells in vitroHum Mol Genet20422435201110.1093/hmg/ddq47821051332 MurakamiKMeguroAOtaMShiotaTNomuraNKashiwagiKMabuchiFIijimaHKawaseKYamamotoTAnalysis of microsatellite polymorphisms within the GLC1F locus in Japanese patients with normal tension glaucomaMol Vis16462466201020309402 PasuttoFKellerKEWeisschuhNStichtHSamplesJRYangYFZenkelMSchlötzer-SchrehardtUMardinCYFrezzottiPVariants in ASB10 are associated with open-angle glaucomaHum Mol Genet2113361349201210.1093/hmg/ddr57222156576 MacgregorSHewittAWHysiPGRuddleJBMedlandSEHendersAKGordonSDAndrewTMcEvoyBSanfilippoPGGenome-wide association identifies ATOH7 as a major gene determining human optic disc sizeHum Mol Genet1927162724201010.1093/hmg/ddq14420395239 VenturiniCNagAHysiPGWangJJWongTYHealeyPRMitchellPHammondCJViswanathanACWellcome Trust Case Control Consortium 2 and BMES GWAS GroupClarifying the role of ATOH7 in glaucoma endophenotypesBr J Ophthalmol98562566201410.1136/bjophthalmol-2013-30408024457358 GuXReaganAMMcClellanMEElliottMHCaveolins and caveolae in ocular physiology and pathophysiologyProg Retin Eye Res5684106201710.1016/j.preteyeres.2016.09.00527664379 ChenFKleinAPKleinBELeeKETruittBKleinRIyengarSKDuggalPExome array analysis identifies CAV1/CAV2 as a susceptibility locus for intraocular pressureInvest Ophthalmol Vis Sci56544551201410.1167/iovs.14-1520425525164 AgaMBradleyJMWanchuRYangYFAcottTSKellerKEDifferential effects of caveolin-1 and −2 knockdown on aqueous outflow and altered extracellular matrix turnover in caveolin-silenced trabecular meshwork cellsInvest Ophthalmol Vis Sci5554975509201410.1167/iovs.14-1451925103269 KuoCYLinYCYangJJYangVCInteraction abolishment between mutant caveolin-1(Δ62-100) and ABCA1 reduces HDL-mediated cellular cholesterol effluxBiochem Biophys Res Commun414337343201110.1016/j.bbrc.2011.09.07021951852 BaileyJNLoomisSJKangJHAllinghamRRGharahkhaniPKhorCCBurdonKPAschardHChasmanDIIgoRPJrANZRAG ConsortiumGenome-wide association analysis identifies TXNRD2, ATXN2 and FOXC1 as susceptibility loci for primary open-angle glaucomaNat Genet48189194201610.1038/ng.348226752265 BurdonKPCrawfordACassonRJHewittAWLandersJDanoyPMackeyDAMitchellPHealeyPRCraigJEGlaucoma risk alleles at CDKN2B-AS1 are associated with lower intraocular pressure, normal-tension glaucoma, and advanced glaucomaOphthalmology11915391545201210.1016/j.ophtha.2012.02.00422521085 ChenYHughesGChenXQianSCaoWWangLWangMSunXGenetic variants associated with different risks for high tension glaucoma and normal tension glaucoma in a Chinese populationInvest Ophthalmol Vis Sci5625952600201510.1167/iovs.14-1626925711633 WiggsJLYaspanBLHauserMAKangJHAllinghamRROlsonLMAbdrabouWFanBJWangDYBrodeurWCommon variants at 9p21 and 8q22 are associated with increased susceptibility to optic nerve degeneration in glaucomaPLoS Genet8e1002654201210.1371/journal.pgen.100265422570617 KathiresanSVoightBFPurcellSMusunuruKArdissinoDMannucciPMAnandSEngertJCSamaniNJSchunkertHWellcome Trust Case Control ConsortiumGenome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variantsNat Genet41334341200910.1038/ng.32719198609 BurdonKPMacgregorSHewittAWSharmaSChidlowGMillsRADanoyPCassonRViswanathanACLiuJZGenome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1Nat Genet43574578201110.1038/ng.82421532571 ShigaYNishiguchiKMKawaiYKojimaKSatoKFujitaKTakahashiMOmodakaKAraieMKashiwagiKGenetic analysis of Japanese primary open-angle glaucoma patients and clinical characterization of risk alleles near CDKN2B-AS1, SIX6 and GAS7PLoS One12e0186678201710.1371/journal.pone.018667829261660 CarnesMULiuYPAllinghamRRWhighamBTHavensSGarrettMEQiaoCKatsanisNWiggsJLPasqualeLRNEIGHBORHOOD Consortium InvestigatorsDiscovery and functional annotation of SIX6 variants in primary open-angle glaucomaPLoS Genet10e1004372201410.1371/journal.pgen.100437224875647 IglesiasAISpringelkampHvan der LindeHSeverijnenLAAminNOostraBKockxCEvan den HoutMCvan IjckenWFHofmanAExome sequencing and functional analyses suggest that SIX6 is a gene involved in an altered proliferation-differentiation balance early in life and optic nerve degeneration at old ageHum Mol Genet2313201332201410.1093/hmg/ddt52224150847 BurdonKPMitchellPLeeAHealeyPRWhiteAJRochtchinaEThomasPBWangJJCraigJEAssociation of open-angle glaucoma loci with incident glaucoma in the Blue Mountains Eye studyAm J Ophthalmol1593136.e1201510.1016/j.ajo.2014.09.02025242315 KuoJZZangwillLMMedeirosFALiebmannJMGirkinCAHammelNRotterJIWeinrebRNQuantitative trait locus analysis of SIX1-SIX6 with retinal nerve fiber layer thickness in individuals of European descentAm J Ophthalmol160123130.e1201510.1016/j.ajo.2015.04.00125849520 Skowronska-KrawczykDZhaoLZhuJWeinrebRNCaoGLuoJFlaggKPatelSWenCKrupaMP16INK4a Upregulation mediated by SIX6 defines retinal ganglion cell pathogenesis in glaucomaMol Cell59931940201510.1016/j.molcel.2015.07.02726365380 ScheetzTEFagaBOrtegaLRoosBRGordonMOKassMAWangKFingertJHGlaucoma risk alleles in the ocular hypertension treatment studyOphthalmology12325272536201610.1016/j.ophtha.2016.08.03627707548 van KoolwijkLMRamdasWDIkramMKJansoniusNMPasuttoFHysiPGMacgregorSJanssenSFHewittAWViswanathanACDCCT/EDIC Research Group; Wellcome Trust Case Control Consortium 2Common genetic determinants of intraocular pressure and primary open-angle glaucomaPLoS Genet8e1002611201210.1371/journal.pgen.100261122570627 HysiPGChengCYSpringelkampHMacgregorSBaileyJNCWojciechowskiRVitartVNagAHewittAWHöhnRBMES GWAS Group; NEIGHBORHOOD Consortium; Wellcome Trust Case Control Consortium 2Genome-wide analysis of multi-ancestry cohorts identifies new loci influencing intraocular pressure and susceptibility to glaucomaNat Genet4611261130201410.1038/ng.308725173106 ChenYLinYVithanaENJiaLZuoXWongTYChenLJZhuXTamPOGongBCommon variants near ABCA1 and in PMM2 are associated with primary open-angle glaucomaNat Genet4611151119201410.1038/ng.307825173107 GharahkhaniPBurdonKPFogartyRSharmaSHewittAWMartinSLawMHCreminKBaileyJNCLoomisSJWellcome Trust Case Control Consortium 2, NEIGHBORHOOD consortiumCommon variants near ABCA1, AFAP1 and GMDS confer risk of primary open-angle glaucomaNat Genet4611201125201410.1038/ng.307925173105 SpringelkampHIglesiasAICuellar-PartidaGAminNBurdonKPvan LeeuwenEMGharahkhaniPMishraAvan der LeeSJHewittAWARHGEF12 influences the risk of glaucoma by increasing intraocular pressureHum Mol Genet2426892699201510.1093/hmg/ddv02725637523 Lessey-MorillonECOsborneLDMonaghan-BensonEGuilluyCO'BrienETSuperfineRBurridgeKThe RhoA guanine nucleotide exchange factor, LARG, mediates ICAM-1-dependent mechanotransduction in endothelial cells to stimulate transendothelial migrationJ Immunol19233903398201410.4049/jimmunol.130252524585879 OkuhiraKFitzgeraldMLTamehiroNOhokaNSuzukiKSawadaJNaitoMNishimaki-MogamiTBinding of PDZ-RhoGEF to ATP-binding cassette transporter A1 (ABCA1) induces cholesterol efflux through RhoA activation and prevention of transporter degradationJ Biol Chem2851636916377201010.1074/jbc.M109.06142420348106 ChenYCaiJJonesDPMitochondrial thioredoxin in regulation of oxidant-induced cell deathFEBS Lett58065966602200610.1016/j.febslet.2006.11.00717113580 CaprioliJMunemasaYKwongJMPiriNOverexpression of thioredoxins 1 and 2 increases retinal ganglion cell survival after pharmacologically induced oxidative stress, optic nerve transection, and in experimental glaucomaTrans Am Ophthalmol Soc107161165200920126492 OrrHTCell biology of spinocerebellar ataxiaJ Cell Biol197167177201210.1083/jcb.20110509222508507 LattanteSMillecampsSStevaninGRivaud-PéchouxSMoigneuCCamuzatADa BarrocaSMundwillerECouarchPSalachasFFrench Research Network on FTD and FTD-ALSContribution of ATXN2 intermediary polyQ expansions in a spectrum of neurodegenerative disordersNeurology83990995201410.1212/WNL.000000000000077825098532 JuYTChangACYSheBRTsaurMLHwangHMChaoCCKCohenSNLin-ChaoSgas7: A gene expressed preferentially in growth-arrested fibroblasts and terminally differentiated Purkinje neurons affects neurite formationProc Natl Acad Sci USA951142311428199810.1073/pnas.95.19.114239736752 WengerDARafiMALuziPDattoJCostantino-CeccariniEKrabbe disease: Genetic aspects and progress toward therapyMol Genet Metab7019200010.1006/mgme.2000.299010833326 LiuYGibsonJWheelerJKweeLCSantiago-TurlaCMAkafoSKLichterPRGaasterlandDEMoroiSEChallaPGALC deletions increase the risk of primary open-angle glaucoma: The role of Mendelian variants in complex diseasePLoS One6e27134201110.1371/journal.pone.002713422073273 WilliamsSECarmichaelTRAllinghamRRHauserMRamsayMThe genetics of POAG in black South Africans: A candidate gene association studySci Rep58378201510.1038/srep0837825669751 VishalMSharmaAKauraniLAlfanoGMookherjeeSNartaKAgrawalJBhattacharyaIRoychoudhurySRayJGenetic association and stress mediated down-regulation in trabecular meshwork implicates MPP7 as a novel candidate gene in primary open angle glaucomaBMC Med Genomics915201610.1186/s12920-016-0177-627001270 AcharyaMMookherjeeSBhattacharjeeAThakurSKBandyopadhyayAKSenAChakrabartiSRayKEvaluation of the OPTC gene in primary open angle glaucoma: functional significance of a silent changeBMC Mol Biol821200710.1186/1471-2199-8-2117359525 LuYVitartVBurdonKPKhorCCBykhovskayaYMirshahiAHewittAWKoehnDHysiPGRamdasWDNEIGHBOR ConsortiumGenome-wide association analyses identify multiple loci associated with central corneal thickness and keratoconusNat Genet45155163201310.1038/ng.250623291589 ChuaJThamYCLiaoJZhengYAungTWongTYChengCYEthnic differences of intraocular pressure and central corneal thickness: The Singapore Epidemiology of Eye Diseases studyOphthalmology12120132022201410.1016/j.ophtha.2014.04.04124950592 RamdasWDvan KoolwijkLMEIkramMKJansoniusNMde JongPTVMBergenAABIsaacsAAminNAulchenkoYSWolfsRCA genome-wide association study of optic disc parametersPLoS Genet6e1000978201010.1371/journal.pgen.100097820548946 SpringelkampHHöhnRMishraAHysiPGKhorCCLoomisSJBaileyJNGibsonJThorleifssonGJanssenSFBlue Mountains Eye Study-GWAS group; NEIGHBORHOOD Consortium; Wellcome Trust Case Control Consortium 2 (WTCCC2)Meta-analysis of genome-wide association studies identifies novel loci that influence cupping and the glaucomatous processNat Commun54883201410.1038/ncomms588325241763 SpringelkampHIglesiasAIMishraAHöhnRWojciechowskiRKhawajaAPNagAWangYXWangJJCuellar-PartidaGNEIGHBORHOOD ConsortiumNew insights into the genetics of primary open-angle glaucoma based on meta-analyses of intraocular pressure and optic disc characteristicsHum Mol Genet26438453201728073927 AxenovichTZorkoltsevaIBelonogovaNvan KoolwijkLMBorodinPKirichenkoABabenkoVRamdasWDAminNDesprietDDLinkage and association analyses of glaucoma related traits in a large pedigree from a Dutch genetically isolated populationJ Med Genet48802809201110.1136/jmedgenet-2011-10043622058429 KhawajaAPViswanathanACAre we ready for genetic testing for primary open-angle glaucoma?Eye (Lond)32877883201810.1038/s41433-017-0011-129379103

Common variants and their associations to POAG risk and/or endophenotypes and interactions. POAG, primary open-angle glaucoma; IOP, intraocular pressure; CCT, central corneal thickness; CA, cup area; DA, disc area; VCDR, vertical cup-to-disc ratio; RNFL, retinal nerve fiber layer.

Glaucoma genomic loci (GLC1A-P), candidate genes and locations and their associated glaucoma type.

Locus Gene Location Glaucoma type
GLC1A MYOC 1q24.3-q25.2 POAG/JOAG
GLC1B – 2cen-q13 POAG, early onset
GLC1C – 3q21-q24 POAG
GLC1D – 8q23 POAG, early onset
GLC1E OPTN 10p13 POAG/NTG
GLC1F ASB10 7q36 POAG
GLC1G WDR36 5q22 POAG
GLC1H – 2p16-p15 POAG
GLC1I – 15q11-q13 POAG
GLC1J – 9q22 JOAG
GLC1K – 20p12 JOAG
GLC1L – 3p22-p21 POAG
GLC1M – 5q22 JOAG
GLC1N – 15q22-q24 JOAG
GLC1O NTF4 19q13.3 POAG
GLC1P Possibly TBK1 12q24 POAG

MYOC, myocilin; OPTN, optineurin; ASB10, ankyrin repeat and SOCS box containing 10; WDR36, WD repeat domain 36; NTF4, neurotrophin 4; TBK1, TANK-binding kinase 1.

Candidate genes and their possible association to glaucoma pathogenesis.

Gene Location Possible glaucoma mechanism/effect
MYOC/TIGR 1q24 TM, outflowa
CYP1B1 2p22.2 Anterior segment dysgenesis
OPTN 10p13 Autophagy, apoptosis
TBK1 12q14 Autophagy, inflammatory response
WDR36 5q22 TM via apoptosis
NTF4 19q13.33 Impaired neuronal survival
ASB10 7q36 Outflow
ATOH7 10q21 DA, VCDR, CA, POAG risk
CAV1/CAV2 7q31 IOP changes, outflow
CDKN2B-AS1 9p21 VCDR
SIX6 14q23 VCDR, myopia, reduced RNFL thickness
TMCO1 1q24.1 IOP changes, increased POAG risk
ABCA1 9q31 Inflammatory response, neurodegeneration
AFAP1 4p16.1 Unknown
ARHGEF12 11q23.3 IOP changes, outflow
TXNRD2 22q11 Oxidative stress
FOXC1 6p25.3 Anterior segment dysgenesis
ATXN2 12q24.12 Neurodegeneration
GAS7 17p13 CA, IOP changes
GALC 14q31.3 Increased POAG risk

Outflow, aqueous humor outflow. TM, trabecular meshwork; DA, disc area; VCDR, vertical cup-to-disc ratio; CA, cup area; POAG, primary open angle glaucoma; RNFL, retinal nerve fiber layer.